InMode (INMD) EPS (Diluted) Growth (3y) (2021 - 2026)
InMode (INMD) EPS (Diluted) Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -12.16% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 19.81% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 50.83% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -6.12% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 33.46% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 11.48% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 1,810.75% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 18.07% |
| 10 | InMode | 912.21 Mn | 497.04 Mn | 71.52 Mn | 644.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.35% |
| Dec 31, 2025 | 7.16% |
| Sep 30, 2025 | -16.61% |
| Jun 30, 2025 | -8.08% |
| Mar 31, 2025 | -10.00% |
| Dec 31, 2024 | -33.36% |
| Sep 30, 2024 | 5.69% |
| Jun 30, 2024 | -16.63% |
| Mar 31, 2024 | -4.38% |
| Dec 31, 2023 | 20.95% |
| Sep 30, 2023 | 24.12% |
| Jun 30, 2023 | 91.89% |
| Mar 31, 2023 | 82.48% |
| Dec 31, 2022 | 21.00% |
| Sep 30, 2022 | 40.01% |
| Jun 30, 2022 | 31.96% |
| Mar 31, 2022 | 35.91% |
| Dec 31, 2021 | 482.66% |
| Sep 30, 2021 | 61.26% |
| Jun 30, 2021 | 63.79% |